STEVEN M KLOSK
CIK 1192621 · President & CEO · last filed 2026-01-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$341.1K
Companies
5
Total Filings
78
Lifetime Open-Market Net
-$72.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LSTA | Director | 95,815 | $3.56 | $341.1K | $0 | 4 | 2026-01-13 |
| Bolt Projects Holdings, Inc. (BSLKW) Delisted | Director | 57,500 | $0.02 | $1.2K | $0 | 2 | 2024-11-27 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Director | 151,390 | $6.40 | $968.3K | $0 | 10 | 2022-01-12 |
| CAMBREX CORP (CBM) Delisted | President & CEO | 163,706 | — | — | -$72.51M | 58 | 2019-12-05 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Director | 32,000 | — | — | $39.9K | 4 | 2015-06-04 |
Recent Filings · Page 3 of 8
78 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-12 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$1.82M | EDGAR |
| 2018-01-10 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-01 | CAMBREX CORP (CBM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-03 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$197.0K | EDGAR |
| 2017-09-05 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$549.7K | EDGAR |
| 2017-08-02 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$668.0K | EDGAR |
| 2017-07-05 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$647.3K | EDGAR |
| 2017-06-02 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$581.6K | EDGAR |
| 2017-05-18 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +2,565 | $0 | EDGAR |
| 2017-05-02 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$629.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.